Co-Director, University of Minnesota Gamma Knife Center
Medical Director, Ridgeview Regional Radiation Oncology
Radiation Oncology
Paul Sperduto is an expert in the field of Radiation Oncology. He studied medicine at Duke University School of Medicine. Duke University School of Medicine is a one of the best medicals schools. Duke University School of Medicine has a rank of 8 in research and a 29 in primary care He over the years received 3 awards: "Regional Top Doctor", "CMS Meaningful Use Stage 1 Certification" and "Top MD". Paul Sperduto is also published. He has 35 publications published. The lastest publication: "Prognostic factors after conservative surgery and radiation therapy for early stage breast cancer.' He is registered with Medicare and accepts Medicare payments.
Publications
- Integrating bevacizumab and radiation treatment of brain metastasis: is there sense and sensibility in this approach?
- Secondary Analysis of RTOG 9508, a Phase 3 Randomized Trial of Whole-Brain Radiation Therapy Versus WBRT Plus Stereotactic Radiosurgery in Patients With 1-3 Brain Meta...
- Radiobiological basis of SBRT and SRS.
- The accuracy of predicting survival in individual patients with Cancer.
- In reply to robins et Al.
- The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast Cancer.
- A Phase 3 Trial of Whole Brain Radiation Therapy and Stereotactic Radiosurgery Alone Versus WBRT and SRS With Temozolomide or Erlotinib for Non-Small Cell Lung Cancer ...
- In regard to Yamamoto et al.
- Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases.
- Reply to drs. Mulvenna and holt.
- Effect of Tumor Subtype on Survival and the Graded Prognostic Assessment for Patients With Breast Cancer and Brain Metastases.
- Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 pati...
- What is your patient's GPA and why does it matter? Managing brain metastases and the cost of hope.
- Stereotactic radiosurgery in the management of brain metastases from primary thyroid Cancers.
- A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database.
- A review of stereotactic radiosurgery in the management of brain metastases.
- A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases.
- Prognostic factors after conservative surgery and radiation therapy for early stage breast Cancer.
- Multifocal inflammatory leukoencephalopathy after fluorouracil and levamisole therapy for colon Cancer.
- Stereotactic radiosurgery in pediatric patients.
- Radiosurgery, cost-effectiveness, gold standards, the scientific method, cavalier cowboys, and the cost of hope.
- The in vitro radiosensitization of human glioblastoma with pentoxifylline.
- Neuropsychological effects of cranial radiation: current knowledge and future directions.
- Stereotactic radiosurgery for recurrent malignant gliomas.
- Knee flexion contractures in myelodysplasia.
- Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method.
- Effects of advanced nursing care on quality of life and cost outcomes of women diagnosed with breast Cancer.
- Photodynamic therapy for chest wall recurrence in breast Cancer.
- Twenty-year survival in glioblastoma: a case report and molecular profile.
- A validation study of a new prognostic index for patients with brain metastases: the Graded Prognostic Assessment.
- Spontaneous regression of squamous cell lung carcinoma with adrenal metastasis.
- Radiation Therapy Oncology Group. Research Plan 2002-2006. Cancer Prevention and Control Committee.
- Purchasing oncology services. Kerr L. White Institute/American Cancer Society Task Force on Purchasing Oncology Services.
- Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 rando...
Schools
Duke University
Duke University Mc
National Cancer Institute
Conditions Treated
Doctors Specialties
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
- Top MD
Education
-
Duke University Hospital
-
Duke University School of Medicine
Hospital
-
Ridgeview Medical Center
-
University of Minnesota Medical Center, Fairview
Drug Facts
| NPI NUMBER |
|
1891789053 |
| NPPES Provider LastName |
|
SPERDUTO |
| NPPES Provider FirstName |
|
PAUL |
| NPPES Provider ZIPCode |
|
553871760 |
| NPPES Provider State |
|
MN |
| Specialty Description |
|
Radiation Oncology |
| Total Claim Count |
|
204.0 |
| Distinct Opioid Count |
|
0.0 |
| Opioid Claim Count |
|
0.0 |
| Percent Opioid Claims |
|
0.0 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
| National Provider Identifier [NPI] |
1891789053 |
| Last Name Of The Provider |
SPERDUTO |
| First Name Of The Provider |
PAUL |
| View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog
